|
06-05-2010, 05:17 PM
|
|||
|
|||
Amgen drug cuts prostate cancer bone problem risk
A third pivotal trial of Amgen Inc's denosumab found that it delayed by 21 percent the risk of fractures and other bone complications in men with advanced prostate cancer compared with current therapy.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Amgen Drug Gets Priority Review For Bone Cancer | cancerfr | Bone Cancer | 0 | 07-17-2010 09:40 AM |
| Amgen drug cuts prostate cancer bone problems | cancerfr | Bone Cancer | 0 | 06-07-2010 07:43 PM |
| Corrected: Amgen drug cuts prostate cancer bone problems | cancerfr | Bone Cancer | 0 | 06-05-2010 05:17 PM |
| Prostate drug cuts cancer risk: study | cancerfr | Latest Cancer News | 0 | 04-01-2010 04:05 AM |
Linear Mode
